In summary, we found that a still uncharacterized protein mainly expressed by breast cancer cell lines can induce HAS2 expression and HA secretion by surrounding fibroblasts and that modification of the stromal ECM can contribute to modulate cancer progression. The gene discussed is HAS2; the disease is cancer.